Trials / Completed
CompletedNCT05249257
Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity
A Phase 2, Multicenter, Observational Study to Assess the Durability and Safety of Collagenase Clostridium Histolyticum Injected With GRID Technique in Buttocks or Thigh Cellulite With Laxity in Adult Females
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Endo Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.
Conditions
Timeline
- Start date
- 2022-01-25
- Primary completion
- 2022-09-12
- Completion
- 2022-09-12
- First posted
- 2022-02-21
- Last updated
- 2023-01-19
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05249257. Inclusion in this directory is not an endorsement.